News
Children and young adults with depression, schizophrenia, ADHD, asthma and epilepsy can get great relief from medications to ...
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) ...
Scientists developed a groundbreaking antivenom cocktail using antibodies from a hyperimmune human donor and a small-molecule ...
A study from the ORIGINS cohort in Western Australia assessed the diets of one-year-old children, comparing intake to ...
Researchers in Japan found that estrogen produced within the brain, called neuroestrogen, suppresses appetite and reduces ...
The massive national effort to return the Medicaid enrollment process to its pre-pandemic rules starting in April 2023 may have disrupted the care of people receiving treatment for opioid addiction, a ...
New research from the Netherlands Institute for Neuroscience maps the similarities and differences between the three most common brain disorders.
About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 million by 2030.
Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage.
Mitochondrial diseases affect approximately 1 in 5,000 people worldwide, causing debilitating symptoms ranging from muscle weakness to stroke-like episodes.
A growing resistance to antibiotics is complicating the treatment of urinary tract infections (UTIs) in Malawi, with new research revealing that nearly half of women presenting with symptoms at a ...
The country's top nonpartisan government watchdog has confirmed it is examining the costs of running the nation's only active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results